Nakamura S - Search Results

1

Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib.

Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Shibata H, Aoki T, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Kaibori M, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: nakamura s. Cancer Med. 2023 Jan;12(1):325-334. doi: 10.1002/cam4.4854. Epub 2022 Jun 3. Cancer Med. 2023. PMID: 35666040 Free PMC article.

2

Actual invasive potential of human hepatocellular carcinoma revealed by in situ gelatin zymography.

Kaneyoshi T, Nakatsukasa H, Higashi T, Fujiwara K, Naito I, Nouso K, Kariyama K, Kobayashi Y, Uemura M, Nakamura SI, Iwasaki Y, Tsuji T. Kaneyoshi T, et al. Among authors: nakamura si. Clin Cancer Res. 2001 Dec;7(12):4027-32. Clin Cancer Res. 2001. PMID: 11751497

3

Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.

Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, Tsuji T. Yoshida Y, et al. Among authors: nakamura si. Acta Med Okayama. 2001 Dec;55(6):349-55. doi: 10.18926/AMO/32003. Acta Med Okayama. 2001. PMID: 11779097 Free article.

4

Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.

Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y. Uemura M, et al. Among authors: nakamura s. Cancer. 2003 May 15;97(10):2474-9. doi: 10.1002/cncr.11374. Cancer. 2003. PMID: 12733146 Free article.

5

Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma.

Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I, Shiratori Y. Fujiwara K, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2004 Oct;19(10):1121-7. doi: 10.1111/j.1440-1746.2004.03467.x. J Gastroenterol Hepatol. 2004. PMID: 15377288

6

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y. Uematsu S, et al. Among authors: nakamura s. J Gastroenterol Hepatol. 2005 Apr;20(4):583-8. doi: 10.1111/j.1440-1746.2005.03726.x. J Gastroenterol Hepatol. 2005. PMID: 15836707

7

Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival.

Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, Miyake Y, Ohnishi H, Miyoshi K, Iwado S, Iwasaki Y, Sakaguchi K, Shiratori Y. Tanaka H, et al. Among authors: nakamura s. Liver Int. 2006 Jun;26(5):543-51. doi: 10.1111/j.1478-3231.2006.01270.x. Liver Int. 2006. PMID: 16761998

8

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y. Nakamura S, et al. Am J Gastroenterol. 2006 Sep;101(9):2038-43. doi: 10.1111/j.1572-0241.2006.00681.x. Epub 2006 Jul 18. Am J Gastroenterol. 2006. PMID: 16848811

9

Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.

Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y. Nakamura S, et al. J Gastroenterol Hepatol. 2006 Aug;21(8):1281-5. doi: 10.1111/j.1440-1746.2006.04271.x. J Gastroenterol Hepatol. 2006. PMID: 16872310

10

Twist expression promotes migration and invasion in hepatocellular carcinoma.

Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Matsuo N, et al. Among authors: nakamura s. BMC Cancer. 2009 Jul 18;9:240. doi: 10.1186/1471-2407-9-240. BMC Cancer. 2009. PMID: 19615090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,872 results

Search Page